Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
teva
Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical Industry Company NYSE:TEVA, PNG, 1248x682px, Teva Pharmaceutical
Teva investors fret over $41bn generic drugs deal | Financial Times
With Allergan deal sealed, Teva turns its attention to branded M&A | Fierce Pharma
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva lone New York defendant after Allergan opioid settlement - Globes
Teva to Buy Allergan's Generic-Drug Unit
Teva, Allergan, Mylan Rally Following Sell-Off On DOJ Antitrust Probe | Stock News & Stock Market Analysis - IBD
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
Teva to Buy Allergan Generic Drug Business for $40.5 Billion
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva-Allergan deal will not impact Indian pharma firms, say experts | Business Standard News
以色列藥廠Teva砸巨資併購Allergan學名藥部門- 自由財經
Actavis Pharmaceutical Industry Teva Pharmaceutical Industries Business Pharmacy, PNG, 800x600px, Actavis, Allergan, Allergan Inc, Brand, Business
Teva Allergan Merger
Teva to switch generics focus to Allergan | Pharmafile
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva, Allergan Get FTC Approval for Generics Purchase - WSJ
NY charges Teva, Allergan with fraud over opioids - www.israelhayom.com
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | FiercePharma
Israel's Teva to buy Allergan Generics for $40.5bn - Pharmaceutical Technology
Allergan steps away from generics with sale to Teva | Business | Chemistry World
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
